Related Experiment Video
Updated: Jun 10, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Absorbed EVELISA: a diagnostic test with improved specificity for Johne's disease in cattle
Mary C Scott1, John P Bannantine, Yumiko Kaneko
1Center for Wildlife Health, Department of Forestry, Wildlife, and Fisheries, The University of Tennessee, Knoxville, Tennessee 37996, USA.
A new Johne's disease (JD) test, EVA-ELISA, shows higher sensitivity and specificity than commercial ELISA tests. This improved diagnostic tool uses Mycobacterium phlei antigens to reduce cross-reactive antibodies, aiding in JD control in dairy herds.
Area of Science:
- Veterinary Immunology
- Diagnostic Microbiology
- Dairy Herd Health
Background:
- Enzyme-linked immunosorbent assays (ELISAs) are crucial for Johne's disease (JD) control in dairy cattle.
- A novel ELISA, EVELISA, was developed showing higher sensitivity than existing commercial tests.
- Concerns about cross-reactive antibodies in EVELISA prompted further investigation.
Purpose of the Study:
- To evaluate the performance of EVELISA, particularly addressing false-positive reactions.
- To investigate and mitigate cross-reactivity issues in JD serological testing.
- To compare the diagnostic accuracy of a modified EVELISA (EVA-ELISA) against a commercial ELISA.
Main Methods:
- Serum samples from suspected JD cases and JD-free herds were tested using EVELISA and commercial ELISA.
- Antibody absorption with Mycobacterium phlei antigens was employed to reduce cross-reactivity in EVELISA.
- Sensitivity and specificity were estimated using samples from JD-negative and JD-positive herds (fecal culture confirmed), with Bayesian analysis for further comparison.
Main Results:
- Over 70% of samples from a JD-free herd showed false-positive reactions with the initial EVELISA and commercial ELISA.
- Antibody absorption with M. phlei significantly reduced false positives in EVELISA, classifying only 8 samples as positive compared to 27 by commercial ELISA.
- EVA-ELISA demonstrated high sensitivity (97.1%) and specificity (100%), outperforming commercial ELISA (48.5% sensitivity, 97.4% specificity).
Conclusions:
- Cross-reactive antibodies against environmental mycobacteria contribute to false positives in JD ELISAs.
- The EVA-ELISA, utilizing M. phlei absorption, significantly enhances diagnostic specificity.
- EVA-ELISA offers a more sensitive and specific diagnostic approach for Johne's disease control in dairy herds.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Pyelonephritis II: Diagnostic Studies and Management

